Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study

导出原文传递

翻译打印收藏纠错

作者： van Lunzen, Jan ^[1] ; Antinori, Andrea ^[2] ; Cohen, Calvin J. ^[3] ; Arribas, Jose R. ^[4] ; Wohl, David A. ^[5] ; Rieger, Armin ^[6] ; Rachlis, Anita ^[7] ; Bloch, Mark ^[8] ; Segal-Maurer, Sorana ^[9] ; Garner, Will ; Porter, Danielle ; Bosse, Matthew ; Piontkowsky, David ; Chuck, Susan K. ; De-Oertel, Shampa

作者单位： Med Univ Vienna, Vienna, Austria ^[1] Holdsworth House Med Practice, Sydney, NSW, Australia ^[2] Gilead Sci Inc, Foster City, CA 94404 USA ^[3] Univ Med Ctr, Infect Dis Unit, D-20246 Hamburg, Germany ^[4] Univ N Carolina, Chapel Hill, NC USA ^[5] Univ Toronto, Toronto, ON, Canada ^[6] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy ^[7] Hosp Univ La Paz, IdiPAZ, Madrid, Spain ^[8] New York Hosp Queens, Flushing, NY USA ^[9]

关键词 antiretroviral agents Atripla Complera Eviplera HIV-1 patient reported outcome (5-7 from MeSH)

发布时间 2016-04-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交